scispace - formally typeset
D

Davide Zella

Researcher at University of Maryland, Baltimore

Publications -  100
Citations -  4555

Davide Zella is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: T cell & Virus. The author has an hindex of 31, co-authored 94 publications receiving 3753 citations. Previous affiliations of Davide Zella include Medical Research Council & University of Maryland Biotechnology Institute.

Papers
More filters
Journal ArticleDOI

Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX

TL;DR: The structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX is deciphered, shedding new light on structure-based rational design of different classes of p 53 activators for potential therapeutic use.
Journal ArticleDOI

Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders

TL;DR: Low concentrations of epigallocatechin-3-gallate, the major green tea catechin, induces HO-1 by ARE/Nrf2 pathway in hippocampal neurons, and by this induction, it is able to protect neurons against different models of oxidative damages and identify a novel class of compounds that could be used for therapeutic purposes as preventive agents against cognitive decline.
Journal ArticleDOI

TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.

TL;DR: The ability of TRAIL to promote the survival/proliferation of endothelial cells without inducing NF-&kgr;B activation and inflammatory markers suggests that the TRAIL/TRAIL-R system plays an important role in endothelial cell physiology.
Journal Article

Extracellular HIV-1 Tat Protein Up-Regulates the Expression of Surface CXC-Chemokine Receptor 4 in Resting CD4+ T Cells

TL;DR: The data indicate a potentially important role for extracellular Tat in rendering bystander CD4+ T cells more susceptible to infection with X4-tropic HIV-1 isolates.